Amine substituted xanthinyl compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3152

Patent

active

058078614

ABSTRACT:
A method for treating a disease caused by an undesirable cell response mediated by a proliferative intracellular signaling pathway is provided wherein an effective amount of a compound is administered. The compound, resolved enantiomers, diastereomers, hydrates, salts, solvates and mixtures thereof, has the formula

REFERENCES:
patent: 3245994 (1966-04-01), Klinger et al.
patent: 3422107 (1969-01-01), Mohler et al.
patent: 3737433 (1973-06-01), Mohler et al.
patent: 4061753 (1977-12-01), Bodor et al.
patent: 4144340 (1979-03-01), Offermans et al.
patent: 4275064 (1981-06-01), Bodor et al.
patent: 4279992 (1981-07-01), Boguslaski et al.
patent: 4299832 (1981-11-01), Brown et al.
patent: 4374837 (1983-02-01), Favier et al.
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4542137 (1985-09-01), Klessing et al.
patent: 4558051 (1985-12-01), Sunshine et al.
patent: 4565817 (1986-01-01), Korbonits et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4618612 (1986-10-01), Baglioni
patent: 4636507 (1987-01-01), Kreutzer et al.
patent: 4784994 (1988-11-01), Romer et al.
patent: 4833146 (1989-05-01), Gebert et al.
patent: 4845081 (1989-07-01), Sloan
patent: 4965271 (1990-10-01), Mandell et al.
patent: 5039666 (1991-08-01), Novick, Jr.
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5118500 (1992-06-01), Hanel et al.
patent: 5126340 (1992-06-01), Tseng et al.
patent: 5196439 (1993-03-01), Sugimoto et al.
patent: 5247086 (1993-09-01), Cain et al.
patent: 5272153 (1993-12-01), Mandell et al.
patent: B13737433 (1987-03-01), Mohler et al.
Bianco et al., Blood, 76: Supplement 1 (522), p. 133a, "Pentoxifylline (PTX) and GM-CSF Decrease Tumor Necrosis Factor-ALPHA (TNF-.alpha.) Levels in Patients Undergoing Allogeneic Bone Marrow Transplantation (BMT)", 1990.
Bianco et al., Blood, 78:5, pp. 1205-1211, "Phase I-II Trial of Pentoxifylline for the Prevention of Transplant-Related Toxicities Following Bone Marrow Transplantation", Sep. 1991.
Bursten et al., The Journal of Biological Chemistry, vol. 266, No. 31, pp. 20732-20743, "Interleukin-1 Rapidly Stimulates Lysophosphatidate Acyltransferase and Phosphatidate Phpsphohydrolase activities in Human Mesangial Cells", Nov. 1991.
Davis et al., Applied Environment Microbial., 48:2, pp. 327-331, "Microbial Models of Mammalian Metabolism: Microbial Reduction and Oxidation of Pentoxifylline", Aug. 1984.
Ridder., Chemical Abstracts, vol. 60, col. 15892, "Derivatives of dialkylxanthines", Jan. 1964.
Singer et al., Bone Marrow Transplantation, 10:19, pp. 19-25, "Effect of Methylxanthine Derivatives on T Cell Activation", 1992.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Amine substituted xanthinyl compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amine substituted xanthinyl compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amine substituted xanthinyl compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-87607

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.